Intrapleural Tenecteplase for Complicated Parapneumonic Pleural Effusion

Table 1

Key characteristics of the study participants.

S. No.	Age; sex	Concomitant disorder	Baseline respiratory symptoms	Baseline total WBC count (/L)	Baseline CRP (mg/L)	Aspirated pleural fluid glucose (mmol/L)	Aspirated pleural fluid WBC count (cells/μL)	Neutrophil percentage in the pleural fluid (%)	Number of loculations as detected in USG	Number of loculations as detected in CT
1	41; M	None	F, P, D	11	305	Not available	790	82	2	3
2	54; M	Dyslipidemia	F, P, C, S	8	161	6.9	7890	70	1	2
3	33; M	None	P, C, S	16	241	6.8	1420	30	1	1
4	37; M	COVID-19	F, P, D	15	160	Not available	2100	50	1	Not done
5	37; M	None	F, P	14	Not available	2.6	8740	79	1	1
6	34; M	None	F, P, D	24	191	0.2	1306	NA	1	2
7	49; M	Diabetes	P	13	160	7.3	830	87	1	Not done
8	72; M	Liver transplantation and CVA	C, S, D	12	Not available	Not available	1610	80	1	2
9	40; Fe	None	F, P, D	13	Not available	1.1	21780	84	1	1
10	41; M	G6PD deficiency	F, P, D	11	180	0.2	2180	83	1	1
11	56; M	G6PD deficiency, diabetes	F, P, C, S, D	8.8	291	3.9	890	89	2	3
12	48; M	Diabetes, systemic hypertension	P, C, D	13.3	202	13.1	1580	65	1	2
13	68; M	Diabetes, IHD, atrial fibrillation	D	14	206	7.7	2160	88	1	1
14	71; M	Dyslipidemia, CVA	F, P, C, S, D	10	Not available	0.2	7210	90	1	1
15	64; M	None	D	16	Not available	2.2	520	61	2	3

M: male; Fe: female; COVID-19: coronavirus 2019 infection; CVA: cerebrovascular accident; IHD: ischemic heart disease; F: fever; P: chest pain; C: cough; D: dyspnea; USG: ultrasonogram; CT: computed tomography.